Advantages and limitations of laboratory methods for measurement of carcinogen-DNA adducts for epidemiological studies
- 31 December 1992
- journal article
- review article
- Published by Elsevier in Toxicology Letters
- Vol. 64-65, 469-475
- https://doi.org/10.1016/0378-4274(92)90221-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Measurement by 32P-postlabelling of 7-methylguanine levels in white blood cell DNA of healthy individuals and cancer patients treated with dacarbazine and procarbazine. Human data and method development for 7-alkylguaninesCarcinogenesis: Integrative Cancer Research, 1991
- Alkyl and aryl carcinogen adducts detected in human peripheral lungCarcinogenesis: Integrative Cancer Research, 1989
- Evaluation of 32P-postlabeling analysis of DNA from exfoliated oral mucosa cells as a means of monitoring exposure of the oral cavity to genotoxic agentsCarcinogenesis: Integrative Cancer Research, 1989
- Covalent DNA Damage in Tissues of Cigarette Smokers as Determined by 32P-Postlabeling AssayJNCI Journal of the National Cancer Institute, 1989
- Evaluation of DNA damage in the oral mucosa of tobacco users and non-users by 32P-adduct assayCarcinogenesis: Integrative Cancer Research, 1988
- Modification of DNA by mitomycin C in cancer patients detected by 32P-postlabeling analysisMutation Research, 1988
- Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy.JCI Insight, 1986
- Detection of Smoking-Related Covalent DNA Adducts in Human PlacentaScience, 1986
- An applied synchronous fluorescence spectrophotometric assay to study benzo[a]pyrene-diolepoxide-DNA adductsCarcinogenesis: Integrative Cancer Research, 1985
- Mechanisms of chemical carcinogenesisCancer, 1981